Avenue Therapeutics(ATXI) - 2023 Q4 - Annual Report
Avenue Therapeutics(ATXI)2024-03-19 04:15
Table of Contents (Title of Class) Trading Symbol(s) (Name of exchange on which registered) Common Stock, par value $0.0001 per share ATXI Nasdaq Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to . Commissi ...